n-vinyl-2-pyrrolidinone has been researched along with Intestinal Diseases, Parasitic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Costa, RLD; Ferreira, JFS; Gomes, ACP; Katiki, LM; Louvandini, H; Pacheco, PA; Rodrigues, LNC; Veríssimo, CJ | 1 |
| Price, P; Turner, KJ | 1 |
1 trial(s) available for n-vinyl-2-pyrrolidinone and Intestinal Diseases, Parasitic
| Article | Year |
|---|---|
Inclusion complex and nanoclusters of cyclodextrin to increase the solubility and efficacy of albendazole.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Albendazole; Animals; Anthelmintics; Antiparasitic Agents; beta-Cyclodextrins; Biological Availability; Cyclodextrins; Drug Compounding; Intestinal Diseases, Parasitic; Male; Nanoparticles; Nematoda; Nematode Infections; Povidone; Sheep; Sheep Diseases; Solubility | 2018 |
1 other study(ies) available for n-vinyl-2-pyrrolidinone and Intestinal Diseases, Parasitic
| Article | Year |
|---|---|
Immunological consequences of intestinal helminth infections in C57BL mice. Humoral responses to polyvinyl pyrrolidone.
Topics: Animals; Antibody Formation; Enzyme-Linked Immunosorbent Assay; Immunoglobulin G; Immunoglobulin M; Intestinal Diseases, Parasitic; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Nematoda; Nematode Infections; Povidone | 1983 |